Cardiac Toxicity Terminated Phase 3 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00016276Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTreatment